STIM · Neuronetics Inc
United States · RS rating 62 · As of 2026-11-03
| Price | 2.26 USD |
|---|---|
| 1-day change | +9.7% |
| RS rating (overall / 1M / 3M / 12M) | 62 / 65 / 58 / 40 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 37 / 29 / 49 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +23.1% |
| Sales growth Q/Q | +12.0% |
| Distance from 52-week high | +31.5% |
| Market cap (USD) | $117.6M |